KR900014428A - 신규폴리펩타이드 및 그 제조방법 - Google Patents

신규폴리펩타이드 및 그 제조방법 Download PDF

Info

Publication number
KR900014428A
KR900014428A KR1019900003202A KR900003202A KR900014428A KR 900014428 A KR900014428 A KR 900014428A KR 1019900003202 A KR1019900003202 A KR 1019900003202A KR 900003202 A KR900003202 A KR 900003202A KR 900014428 A KR900014428 A KR 900014428A
Authority
KR
South Korea
Prior art keywords
polypeptide
amino acid
acid sequence
following amino
molecule
Prior art date
Application number
KR1019900003202A
Other languages
English (en)
Other versions
KR0132425B1 (ko
Inventor
가즈오 나까하마
요시히꼬 가이쇼
고지 요시무라
레이꼬 사사다
Original Assignee
우메모또 요시마사
다께다야꾸힝 고오교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27463714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR900014428(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 우메모또 요시마사, 다께다야꾸힝 고오교 가부시끼가이샤 filed Critical 우메모또 요시마사
Publication of KR900014428A publication Critical patent/KR900014428A/ko
Application granted granted Critical
Publication of KR0132425B1 publication Critical patent/KR0132425B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

신규폴리펩타이드 및 그 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 실시예1 에서 얻어진 플라스미드 pUNK5 내의 폴리펩타이드(Ⅰ)cDNA를 포함하는 DNA의 제한 효소 지도이며, 뉴클레오티드 서열 및 그로부터 해독된 아미노산서열을 나타내며,
제3도는 실시예1에서 얻어진 본 발명의 폴리펩타이드(Ⅰ)의 아미노산서열(윗줄)과 사람 βNGF의 아미노산서열(아랫줄)과의 비교를 나타낸다.

Claims (10)

  1. 분자내에 하기 아미노산 서열(Ⅱ)를 포함하는 폴리펩타이드(Ⅰ).
  2. 제1항에 있어서, 하기 아미노산 서열(Ⅱ')을 갖는 폴리펩타이드.
  3. 분자 내에 하기 아미노산 서열(Ⅱ)을 포함하는 폴리펩타이드 (Ⅰ)에 대해 코오딩하는 DNA.
  4. 분자 내에 하기 아미노산 서열(Ⅱ)을 포함하는 폴리펩타이드(Ⅰ)에 대해 코오딩하는 DNA를 함유하는 벡터.
  5. 분자 내에 하기 아미노산 서열(Ⅱ)을 포함하는 폴리펩타이드(Ⅰ)에 대해 코오딩하는 DNA을 함유하는 벡터에 의해 형질전환된 형질 전환제.
  6. 제5항에 따른 에스케리키아 콜라이 BL21(DE3)/pENGFT102(FFRM BP-2420).
  7. 제5항에 따른 사카로마이세스 세레비시애 TB39ρ/pANT 341T(FERM BP-2530).
  8. 제5항에 따른 에스케리키아 콜라이 BL21(DE3)/pLyS, pENGFT102(FERM BP-2529).
  9. 제5항에 따른 L-H14-1(FERM BP-2754).
  10. 폴리펩타이드(Ⅰ)에 대해 코오딩하는 DNA를 함유하는 벡터에 의해 형질전환된 형질 전환체를 배지 내에서 배양하고, 폴리펩타이드를 축적하고, 폴리펩타이드를 수집하는 것으로 구성되는, 분자내에 하기 아미노산 서열(Ⅱ)을 포함하는 폴리펩타이드(Ⅰ)의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900003202A 1989-03-10 1990-03-10 신규 폴리펩타이드 및 그 제조방법 KR0132425B1 (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP5898389 1989-03-10
JP127710/1989 1989-05-19
JP12771089 1989-05-19
JP193654/1989 1989-07-26
JP19365489 1989-07-26
JP26361389 1989-10-09
JP263613/1989 1989-10-09
JP1-58983 1989-10-09

Publications (2)

Publication Number Publication Date
KR900014428A true KR900014428A (ko) 1990-10-23
KR0132425B1 KR0132425B1 (ko) 1998-04-14

Family

ID=27463714

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900003202A KR0132425B1 (ko) 1989-03-10 1990-03-10 신규 폴리펩타이드 및 그 제조방법

Country Status (11)

Country Link
US (1) US6709837B1 (ko)
EP (1) EP0386752B1 (ko)
JP (1) JPH0780904B2 (ko)
KR (1) KR0132425B1 (ko)
AT (1) ATE111521T1 (ko)
CA (1) CA2011833C (ko)
DE (1) DE69012377T2 (ko)
DK (1) DK0386752T3 (ko)
ES (1) ES2059854T3 (ko)
HK (1) HK34896A (ko)
IE (1) IE65361B1 (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656435A (en) * 1989-08-28 1997-08-12 Takeda Chemical Industries, Ltd. Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
US6933276B1 (en) 1989-08-30 2005-08-23 Regeneron Pharmaceuticals, Inc. Methods of treating peripheral neuropathies using neurotrophin-3
GR1000980B (el) 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
ATE154389T1 (de) * 1991-02-18 1997-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von menschlichem ngf-2
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
EP0573904B1 (en) * 1992-06-08 2001-09-26 Takeda Chemical Industries, Ltd. Therapeutic agent for neutropenia
WO1994012637A2 (en) * 1992-12-02 1994-06-09 Zymogenetics, Inc. Novel human amyloid protein precursor homologue and kunitz-type inhibitors
JP2732005B2 (ja) * 1992-12-14 1998-03-25 眞一 富永 ヒトｓｔ２をコードするｄｎａ、該ｄｎａの発現産物、該ｄｎａを発現させることによる発現産物の製造方法
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−３遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
US5877016A (en) * 1994-03-18 1999-03-02 Genentech, Inc. Human trk receptors and neurotrophic factor inhibitors
US5681931A (en) * 1995-03-15 1997-10-28 Becton, Dickinson And Company Human restrictin
US5864018A (en) * 1996-04-16 1999-01-26 Schering Aktiengesellschaft Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
WO1998022575A2 (en) * 1996-11-22 1998-05-28 Human Genome Sciences, Inc. Nucleotide sequence of escherichia coli pathogenicity islands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor

Also Published As

Publication number Publication date
JPH03204897A (ja) 1991-09-06
US6709837B1 (en) 2004-03-23
CA2011833A1 (en) 1990-09-10
KR0132425B1 (ko) 1998-04-14
ES2059854T3 (es) 1994-11-16
DE69012377T2 (de) 1995-05-04
EP0386752A1 (en) 1990-09-12
IE65361B1 (en) 1995-10-18
ATE111521T1 (de) 1994-09-15
CA2011833C (en) 2002-11-05
DK0386752T3 (da) 1994-12-05
HK34896A (en) 1996-03-08
IE900785L (en) 1990-09-10
JPH0780904B2 (ja) 1995-08-30
DE69012377D1 (de) 1994-10-20
EP0386752B1 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
KR900014428A (ko) 신규폴리펩타이드 및 그 제조방법
KR880701288A (ko) M-csf의 제법
US5464939A (en) Highly purified protein, production and use thereof
KR890012000A (ko) 인간 b세포 자극인자-2에 대한 수용체 단백질
KR870000427A (ko) 하이브리드 인터페론의 제조방법
KR920701451A (ko) 인체혈청알부민의 n-말단 단편을 함유하는 융합 단백질
AU704515C (en) Novel protein and process for producing the same
IT1153265B (it) Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi
PT81590B (pt) Metodo para a producao de um clone de cdna humanoque exprime eritropoietina biologicamente activa
KR920702417A (ko) Tcf-ii의 아미노산 배열을 코드하는 dna를 함유한 플라스미드, 형질전환세포, 및 이것을 사용하여 생리 활성물질을 생산하는 방법
KR910000796A (ko) 미니-프로인슐린, 이의 제조방법 및 용도
KR910006483A (ko) 재조합 아프로티닌 변이체, 균질하게 프로세싱된 아프로티닌 변이체의 미생물을 이용한 유전공학적 제조 방법 및 그의 치료 용도
ES2088911T3 (es) Gen de la proteasa i de achromobacter y el producto de este gen.
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
KR900700615A (ko) 사람 호중구 화학주성 인자 폴리펩티드의 제조방법
CN105218659B (zh) 人骨形成蛋白2成熟肽及其表达
KR880005264A (ko) 사카로미세스 세레비시아에에서 재조합 인간 psti제법
ATE119938T1 (de) Produktion von menschlichen nervenwachstumsfaktoren.
KR100729830B1 (ko) 페너트라틴을 이용하여 단백질의 세포투과를 증진시키는대장균용발현벡터
HUP9800520A2 (hu) Génexpresszió emlős sejtekben
Dabrowska et al. Dimerization of the polypeptide chains of skeletal muscle tropomyosin
KR890013177A (ko) 신규폴리펩티드 및 그것을 코우드하는 dna
RU96104560A (ru) Способ получения эритропоэтина человека и способ получения фармацевтической композиции
GENES Medium for electrophoresis
Read et al. Two‐dimensional gel resolution of polypeptides specific for autotrophic growth in Thiobacillus versutus

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20101124

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee